BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 30340821)

  • 1. Study on the correlation of modified Blalock Taussig duct occlusion and platelet parameters in congenital heart disease.
    Zhu Y; Zhang Y; Liu Y; Fan X; Ding N; Li Z
    Asian J Surg; 2019 May; 42(5):599-603. PubMed ID: 30340821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive Value of Mean Platelet Volume in Saphenous Vein Graft Disease.
    Kaya U; Koza Y
    Braz J Cardiovasc Surg; 2018; 33(4):317-322. PubMed ID: 30184027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Reverse Blalock-Taussig shunt": application in single ventricle hybrid palliation.
    Baba K; Honjo O; Chaturvedi R; Lee KJ; Van Arsdell G; Caldarone CA; Benson LN
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):352-7. PubMed ID: 23228402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for in-hospital shunt thrombosis and mortality in patients weighing less than 3 kg with functionally univentricular heart undergoing a modified Blalock-Taussig shunt.
    Chittithavorn V; Duangpakdee P; Rergkliang C; Pruekprasert N
    Interact Cardiovasc Thorac Surg; 2017 Sep; 25(3):407-413. PubMed ID: 28520941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High acetylsalicylic acid dosing in infants after modified Blalock-Taussig shunt.
    Saini A; Joshi AD; Cowan KM; Wayne Gatewood C; Kumar STK; Allen J; Shah SH; Nouer SS; Jones T; Knott-Craig CJ; Boston US
    Cardiol Young; 2019 Mar; 29(3):389-397. PubMed ID: 30739623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal Graft Size of Modified Blalock-Taussig Shunt for Biventricular Circulation in Neonates and Small Infants.
    Shibata M; Itatani K; Oka N; Yoshii T; Nakamura Y; Kitamura T; Horai T; Miyaji K
    Int Heart J; 2015; 56(5):533-6. PubMed ID: 26370364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet activation markers in children with congenital heart disease associated with pulmonary arterial hypertension.
    Mese T; Guven B; Yilmazer MM; Karadeniz C; Ozdemir R; Doksoz O
    Congenit Heart Dis; 2018 Jul; 13(4):506-511. PubMed ID: 30019380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mean Platelet Volume (MPV), Platelet Distribution Width (PDW), Platelet Count and Plateletcrit (PCT) as predictors of in-hospital paediatric mortality: a case-control Study.
    Golwala ZM; Shah H; Gupta N; Sreenivas V; Puliyel JM
    Afr Health Sci; 2016 Jun; 16(2):356-62. PubMed ID: 27605950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination between mean platelet volume and platelet distribution width to predict the prevalence and extent of coronary artery disease: results from a large cohort study.
    De Luca G; Secco GG; Verdoia M; Cassetti E; Schaffer A; Coppo L; Marino P
    Blood Coagul Fibrinolysis; 2014 Jan; 25(1):86-91. PubMed ID: 24126247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of hemodilution on outcome after modified Blalock-Taussig shunt operation in children with cyanotic congenital heart disease.
    Sahoo TK; Chauhan S; Sahu M; Bisoi A; Kiran U
    J Cardiothorac Vasc Anesth; 2007 Apr; 21(2):179-83. PubMed ID: 17418728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison Between Patent Ductus Arteriosus Stent and Modified Blalock-Taussig Shunt as Palliation for Infants With Ductal-Dependent Pulmonary Blood Flow: Insights From the Congenital Catheterization Research Collaborative.
    Glatz AC; Petit CJ; Goldstein BH; Kelleman MS; McCracken CE; McDonnell A; Buckey T; Mascio CE; Shashidharan S; Ligon RA; Ao J; Whiteside W; Wallen WJ; Metcalf CM; Aggarwal V; Agrawal H; Qureshi AM
    Circulation; 2018 Feb; 137(6):589-601. PubMed ID: 29042354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete Blalock-Taussig shunt obstruction in < 24 hours post-operative period in a neonate treated emergently using transcatheter angioplasty and low dose local recombinant TPA.
    Patange A; Blake J; Gowda S
    Catheter Cardiovasc Interv; 2014 May; 83(6):964-7. PubMed ID: 24867628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Outcomes after Biologic Graft Use for the Creation of Blalock-Taussig Shunt in Critically Ill Patients with Thrombophilia.
    Azboy D; Temiztürk Z
    Heart Surg Forum; 2020 Oct; 23(6):E718-E724. PubMed ID: 33234223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified Blalock Taussig shunt: a not-so-simple palliative procedure.
    Dirks V; Prêtre R; Knirsch W; Valsangiacomo Buechel ER; Seifert B; Schweiger M; Hübler M; Dave H
    Eur J Cardiothorac Surg; 2013 Dec; 44(6):1096-102. PubMed ID: 23539419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catheter-based interventions for modified Blalock-Taussig shunt obstruction: a 20-year experience.
    Bonnet M; Petit J; Lambert V; Brenot P; Riou JY; Angel CY; Belli E; Baruteau AE
    Pediatr Cardiol; 2015 Apr; 36(4):835-41. PubMed ID: 25560736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duct Stenting Versus Modified Blalock-Taussig Shunt in Neonates With Duct-Dependent Pulmonary Blood Flow: Associations With Clinical Outcomes in a Multicenter National Study.
    Bentham JR; Zava NK; Harrison WJ; Shauq A; Kalantre A; Derrick G; Chen RH; Dhillon R; Taliotis D; Kang SL; Crossland D; Adesokan A; Hermuzi A; Kudumula V; Yong S; Noonan P; Hayes N; Stumper O; Thomson JDR
    Circulation; 2018 Feb; 137(6):581-588. PubMed ID: 29084734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-hospital shunt occlusion in infants undergoing a modified blalock-taussig shunt.
    Guzzetta NA; Foster GS; Mruthinti N; Kilgore PD; Miller BE; Kanter KR
    Ann Thorac Surg; 2013 Jul; 96(1):176-82. PubMed ID: 23673075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modified Blalock-Taussig shunt versus ductal stenting for palliation of cardiac lesions with inadequate pulmonary blood flow.
    McMullan DM; Permut LC; Jones TK; Johnston TA; Rubio AE
    J Thorac Cardiovasc Surg; 2014 Jan; 147(1):397-401. PubMed ID: 24071469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative B-type natriuretic peptide monitoring for the assessment of the magnitude of shunting through Blalock-Taussig anastomoses.
    Mirabile C; Mazzola A; Valeanu L; Lopez-Lopez V; Barbanti C; Biselli C; Hennequin C; Malekzadeh-Milani S; Bojan M
    Int J Cardiol; 2017 Dec; 249():151-155. PubMed ID: 28912041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stenting of modified and classical Blalock-Taussig shunts--lessons learned from seven consecutive cases.
    Krasemann T; Tzifa A; Rosenthal E; Qureshi SA
    Cardiol Young; 2011 Aug; 21(4):430-5. PubMed ID: 21411029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.